Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source - FDA Office of Orphan Products Development (OOPD)


Clinical Trial Description

This is a prospective, multicenter open-label study in adults with CF who are colonized with M. avium complex and/or M. abscessus complex. Subjects will receive two 5-day infusion cycles of IV gallium. The study will evaluate the safety and antimycobacterial effect of two 5-day infusions of IV gallium. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04294043
Study type Interventional
Source Seattle Children's Hospital
Contact Natallia Cameron
Phone 206-884-7550
Email Natallia.Cameron@seattlechildrens.org
Status Recruiting
Phase Phase 1
Start date June 17, 2021
Completion date June 30, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT03532438 - WGS of NTM From Sputum of NTM Lung Disease Patients and From Their Environments
Recruiting NCT04921943 - Hypertonic Saline for MAC Phase 4
Recruiting NCT05280886 - Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)
Completed NCT04024423 - Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis
Completed NCT03748992 - A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection Phase 2
Active, not recruiting NCT06004037 - Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex Phase 2
Enrolling by invitation NCT06262282 - Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
Recruiting NCT03672630 - Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease Phase 2/Phase 3
Recruiting NCT03120481 - Controls for Respiratory Diseases N/A